Orbimed Advisors SC 13D Apollomics / ORBIMED ADVISORS ownership change

Exhibit 1

JOINT FILING AGREEMENT

The undersigned hereby agree that the Statement on Schedule 13D, dated March 29, 2023, with respect to the Class A ordinary shares of Apollomics Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Each of the undersigned agrees to be responsible for the timely filing of this Statement, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the 12^th day of April 2023.

ORBIMED ADVISORS LLC
By:	/s/ Carl L. Gordon
	Name: Carl L. Gordon
	Title: Member
ORBIMED ASIA GP, L.P.
By:	ORBIMED ADVISORS LIMITED, its general partner
By:	/s/ Carl L. Gordon
	Name: Carl L. Gordon
	Title: Director
ORBIMED ADVISORS LIMITED
By:	/s/ Carl L. Gordon
	Name: Carl L. Gordon
	Title: Director
ORBIMED ASIA GP II, L.P.
By:	ORBIMED ADVISORS II LLC, its managing member
By:	s/ Carl L. Gordon
	Name: Carl L. Gordon
	Title: Director
ORBIMED ADVISORS II LIMITED
By:	s/ Carl L. Gordon
	Name: Carl L. Gordon
	Title: Director